These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31034982)

  • 21. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
    Wouters BG; Delahoussaye YM; Evans JW; Birrell GW; Dorie MJ; Wang J; MacDermed D; Chiu RK; Brown JM
    Cancer Res; 2001 Jan; 61(1):145-52. PubMed ID: 11196153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a sequential release nanomaterial for co-delivery of hypoxia-induced tirapazamine and HIF-1α siRNA in cancer therapy.
    Zhang X; Bai Z; Cui Z; Liang W; Shi M; Liu Z; Li K; Wang J; Jiao T; Li J
    Colloids Surf B Biointerfaces; 2025 Jan; 245():114260. PubMed ID: 39305549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production.
    Li H; Zhang W; Ding L; Li XW; Wu Y; Tang JH
    J Biomater Appl; 2019 Apr; 33(9):1202-1213. PubMed ID: 30714472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Siim BG; Pruijn FB; Sturman JR; Hogg A; Hay MP; Brown JM; Wilson WR
    Cancer Res; 2004 Jan; 64(2):736-42. PubMed ID: 14744792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tirapazamine combined with photodynamic therapy improves the efficacy of ABZSO nanoparticles on Echinococcosis granulosus via further enhancing "breaking-then-curing".
    Gong Y; Zhou T; Aimaiti W; Lin Y; Xu Y; Yang J; Huang Z; Wen H; Jiang H; Wang J
    J Photochem Photobiol B; 2023 Nov; 248():112798. PubMed ID: 37820499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
    Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine.
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 2001; 12(8):325-33. PubMed ID: 11589303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
    Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer.
    Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z
    J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PL-W
    Zhao P; Ren S; Liu Y; Huang W; Zhang C; He J
    ACS Appl Mater Interfaces; 2018 Jan; 10(4):3405-3413. PubMed ID: 29313656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
    Yang B; Reynolds CP
    Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
    Lee AE; Wilson WR
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):50-9. PubMed ID: 10662604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
    Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
    Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
    Elwell JH; Siim BG; Evans JW; Brown JM
    Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
    Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
    Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG; Menke DR; Dorie MJ; Brown JM
    Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy.
    Liu C; Jia S; Tu L; Yang P; Wang Y; Ke S; Shi W; Ye S
    ACS Biomater Sci Eng; 2022 May; 8(5):1942-1955. PubMed ID: 35357802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-microenvironment-responsive poly-prodrug encapsulated semiconducting polymer nanosystem for phototherapy-boosted chemotherapy.
    Zhu J; Zhang Y; Li Z; Bao X; Zhou Y; Ma B; Xie Y; Yan P; Wu Z; Zhang Q; Zou J; Chen X
    Mater Horiz; 2023 Jul; 10(8):3014-3023. PubMed ID: 37194333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.